GS-1614

N/A

Report date: 2024/06/28 10:46:31
NME

Base Information

Drug NameGS-1614
Drug Alias NameHIV long-acting injectable NRTTI (Gilead Sciences)GS-1614
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionNucleoside reverse transcriptase translocation inhibitor
TargetsNucleotide reverse transcriptase
Therapy Area/IndicationsAcquired Immunodeficiency Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences Inc
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A